Literature DB >> 17019218

Clonidine in paediatric anaesthesia.

Kahoru Nishina1, Katsuya Mikawa.   

Abstract

PURPOSE OF REVIEW: This review aims to summarize results of recently published studies concerning clonidine application in paediatric anaesthesia, to analyse trends in these studies, and to discuss perspectives of the perioperative use of clonidine for children. RECENT
FINDINGS: Reassessment of clonidine premedication has revealed that oral clonidine is inferior to midazolam for preoperative sedation. Oral or intravenous clonidine has been successfully used for the prevention of sevoflurane-induced agitation during emergence from anaesthesia. Peripheral injection or caudal (epidural) administration of clonidine prolonged the duration and enhanced the quality of postoperative analgesia by local anaesthetics without severe side effects. However, some negative results concerning potentiation of postoperative analgesia with clonidine have been reported.
SUMMARY: Clonidine may be less favored than midazolam as premedication for children because of inferior clonidine-induced sedation. Additional comparative studies are required, however, to confirm this finding. On the other hand, clonidine-induced analgesia may well be useful and find wide application in paediatric anaesthesia. Prospective multicentre trials using a larger number of patients will be needed to verify the usefulness of caudal clonidine for postoperative pain relief. Prophylactic use of clonidine against sevoflurane-induced agitation may represent a new and promising application. Assessment of the efficacy of clonidine in potentiating regional anaesthesia/analgesia by local anaesthetics in children also needs more investigation. Moreover, it may be worthwhile to try new successful applications demonstrated in adults for paediatric anaesthesia.

Entities:  

Year:  2002        PMID: 17019218     DOI: 10.1097/00001503-200206000-00006

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  9 in total

1.  Efficacy and Safety of Clonidine as an Adjuvant to Bupivacaine for Caudal Analgesia in Paediatric Infra-Umbilical Surgeries.

Authors:  Samita Priolkar; Shirley Ann D'Souza
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  Clonidine in paediatrics - a review.

Authors:  Sujatha Basker; Georgene Singh; Rebecca Jacob
Journal:  Indian J Anaesth       Date:  2009-06

Review 3.  Long-term consequences of drugs on the paediatric cardiovascular system.

Authors:  Elizabeth Hausner; Monica L Fiszman; Joseph Hanig; Patricia Harlow; Gwen Zornberg; Solomon Sobel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Efficacy of clonidine as an adjuvant to bupivacaine for caudal analgesia in children undergoing sub-umbilical surgery.

Authors:  Aruna Parameswari; Anand M Dhev; Mahesh Vakamudi
Journal:  Indian J Anaesth       Date:  2010-09

5.  Sciatic lateral popliteal block with clonidine alone or clonidine plus 0.2% ropivacaine: effect on the intra-and postoperative analgesia for lower extremity surgery in children: a randomized prospective controlled study.

Authors:  Kalliopi Petroheilou; Stavros Livanios; Nikolaos Zavras; John Hager; Argyro Fassoulaki
Journal:  BMC Anesthesiol       Date:  2012-02-01       Impact factor: 2.217

6.  Comparative evaluation of midazolam and clonidine as pediatric oral premedication.

Authors:  Sangeeta Sahoo; Manpreet Kaur; Hemant Kumar Tripathy; Ajeet Kumar; Santavana Kohli; Samridhi Nanda
Journal:  Anesth Essays Res       Date:  2013 May-Aug

7.  Comparative study of caudal clonidine and midazolam added to bupivacaine during infra-umbilical surgeries in children.

Authors:  Sadhana Sanwatsarkar; Sahil Kapur; Dipti Saxena; Gaurav Yadav; Nagina Naz Khan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Apr-Jun

Review 8.  Premedication and Induction of Anaesthesia in paediatric patients.

Authors:  Nandini Malay Dave
Journal:  Indian J Anaesth       Date:  2019-09

Review 9.  Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.

Authors:  Fei Tang; Chee M Ng; Henrietta S Bada; Markos Leggas
Journal:  Clin Transl Sci       Date:  2021-05-01       Impact factor: 4.689

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.